Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (sustain-2)

  • Ewa Wajs
  • , Leah Aluisio
  • , Richard Holder
  • , Ella J. Daly
  • , Rosanne Lane
  • , Pilar Lim
  • , Joyce E. George
  • , Randall L. Morrison
  • , Gerard Sanacora
  • , Allan H. Young
  • , Siegfried Kasper
  • , Ahmad Hatim Sulaiman
  • , Cheng Ta Li
  • , Jong Woo Paik
  • , Husseini Manji
  • , David Hough
  • , Jennifer Grunfeld
  • , Hong Jin Jeon
  • , Samuel T. Wilkinson
  • , Wayne C. Drevets
    • Jaskaran B. Singh

Research output: Contribution to journal › Article › peer-review

271   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (sustain-2)'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry